Literature DB >> 7822011

Transmission blockade of Plasmodium falciparum malaria by anti-Pfs230-specific antibodies is isotype dependent.

W Roeffen1, F Geeraedts, W Eling, P Beckers, B Wizel, N Kumar, T Lensen, R Sauerwein.   

Abstract

By use of the parental hybridoma cell line 63F2A2 that produces specific antibodies of immunoglobulin isotype G1 (IgG1; 63F2A2.1) against Pfs230, we attempted to enrich for the synthesis of the downstream switch variant IgG2b and IgG2a monoclonal antibodies (MAbs) of the hybridoma cell line (63F2A2.2b and 63F2A2.2a, respectively). The parental IgG1 did not reduce the Plasmodium falciparum transmission in a bioassay irrespective of the presence of complement. MAbs 63F2A2.2b and 63F2A2.2a were effective in reducing the infectivity of P. falciparum parasites to Anopheles gambiae mosquitoes in membrane-feeding experiments. A transmission reduction of 91% was accomplished by the 63F2A2.2b switch variant, and a reduction of greater than 99% was accomplished by the 63F2A2.2a switch variant, but only in the presence of active human complement. Subsequently, the transmission-reducing effect of MAb 63F2A2.2b or 63F2A2.2a was confirmed in vitro by the rapid lysis of newly formed macrogametes or zygotes in the presence of active complement. MAb 63F2A2.1 did not lyse the newly formed macrogametes or zygotes irrespective of the presence of complement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7822011      PMCID: PMC173018          DOI: 10.1128/iai.63.2.467-471.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Infectivity of cultured Plasmodium falciparum gametocytes to mosquitoes.

Authors:  T Ponnudurai; A H Lensen; G J Van Gemert; M P Bensink; M Bolmer; J H Meuwissen
Journal:  Parasitology       Date:  1989-04       Impact factor: 3.234

2.  The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.

Authors:  I A Quakyi; R Carter; J Rener; N Kumar; M F Good; L H Miller
Journal:  J Immunol       Date:  1987-12-15       Impact factor: 5.422

Review 3.  Immunity to sexual stages of malaria parasites.

Authors:  R Carter; N Kumar; I Quakyi; M Good; K Mendis; P Graves; L Miller
Journal:  Prog Allergy       Date:  1988

4.  Transmission blockade of Plasmodium falciparum: its variability with gametocyte numbers and concentration of antibody.

Authors:  T Ponnudurai; G J van Gemert; T Bensink; A H Lensen; J H Meuwissen
Journal:  Trans R Soc Trop Med Hyg       Date:  1987       Impact factor: 2.184

Review 5.  An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.

Authors:  A C Allison; N E Byars
Journal:  J Immunol Methods       Date:  1986-12-24       Impact factor: 2.303

6.  Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.

Authors:  T L ten Hagen; A J Sulzer; M R Kidd; A A Lal; R L Hunter
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

7.  Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera.

Authors:  P M Graves; R Carter; T R Burkot; I A Quakyi; N Kumar
Journal:  Parasite Immunol       Date:  1988-03       Impact factor: 2.280

8.  Human antibody responses to Pfs 230, a sexual stage-specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated.

Authors:  E M Riley; S Bennett; A Jepson; M Hassan-King; H Whittle; O Olerup; R Carter
Journal:  Parasite Immunol       Date:  1994-02       Impact factor: 2.280

9.  Murine monoclonal isotype switch variants. Detection with rat monoclonal antibodies in ELISA and isolation by sequential sublining.

Authors:  J H Boot; M E Geerts; E R De Groot; L A Aarden
Journal:  J Immunol Methods       Date:  1988-02-10       Impact factor: 2.303

10.  Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka.

Authors:  S Premawansa; A Gamage-Mendis; L Perera; S Begarnie; K Mendis; R Carter
Journal:  Parasite Immunol       Date:  1994-01       Impact factor: 2.280

View more
  29 in total

1.  Immunization of mice with DNA-based Pfs25 elicits potent malaria transmission-blocking antibodies.

Authors:  C A Lobo; R Dhar; N Kumar
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

2.  Structural and Immunological Characterization of Recombinant 6-Cysteine Domains of the Plasmodium falciparum Sexual Stage Protein Pfs230.

Authors:  Nicholas J MacDonald; Vu Nguyen; Richard Shimp; Karine Reiter; Raul Herrera; Martin Burkhardt; Olga Muratova; Krishan Kumar; Joan Aebig; Kelly Rausch; Lynn Lambert; Nikiah Dawson; Jetsumon Sattabongkot; Xavier Ambroggio; Patrick E Duffy; Yimin Wu; David L Narum
Journal:  J Biol Chem       Date:  2016-07-18       Impact factor: 5.157

3.  Structural models for the protein family characterized by gamete surface protein Pfs230 of Plasmodium falciparum.

Authors:  Dietlind L Gerloff; Alison Creasey; Siarhei Maslau; Richard Carter
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

Review 4.  Transmission-Blocking Vaccines: Old Friends and New Prospects.

Authors:  Festus K Acquah; Joshua Adjah; Kim C Williamson; Linda E Amoah
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

5.  Complement-mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230.

Authors:  J Healer; D McGuinness; P Hopcroft; S Haley; R Carter; E Riley
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Naturally acquired immune responses to Plasmodium falciparum sexual stage antigens Pfs48/45 and Pfs230 in an area of seasonal transmission.

Authors:  André Lin Ouédraogo; Will Roeffen; Adrian J F Luty; Sake J de Vlas; Issa Nebie; Edith Ilboudo-Sanogo; Nadine Cuzin-Ouattara; Karina Teleen; Alfred B Tiono; Sodiomon Bienvenu Sirima; Jan-Peter Verhave; Teun Bousema; Robert Sauerwein
Journal:  Infect Immun       Date:  2011-10-03       Impact factor: 3.441

7.  Effect of CpG oligodeoxynucleotides on the immunogenicity of Pfs25, a Plasmodium falciparum transmission-blocking vaccine antigen.

Authors:  Cevayir Coban; Ken J Ishii; Anthony W Stowers; David B Keister; Dennis M Klinman; Nirbhay Kumar
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

8.  A novel plant-produced Pfs25 fusion subunit vaccine induces long-lasting transmission blocking antibody responses.

Authors:  R Mark Jones; Jessica A Chichester; Slobodanka Manceva; Sandra K Gibbs; Konstantin Musiychuk; Moneim Shamloul; Joey Norikane; Stephen J Streatfield; Marga van de Vegte-Bolmer; Will Roeffen; Robert W Sauerwein; Vidadi Yusibov
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

9.  Three members of the 6-cys protein family of Plasmodium play a role in gamete fertility.

Authors:  Melissa R van Dijk; Ben C L van Schaijk; Shahid M Khan; Maaike W van Dooren; Jai Ramesar; Szymon Kaczanowski; Geert-Jan van Gemert; Hans Kroeze; Hendrik G Stunnenberg; Wijnand M Eling; Robert W Sauerwein; Andrew P Waters; Chris J Janse
Journal:  PLoS Pathog       Date:  2010-04-08       Impact factor: 6.823

10.  Human host-derived cytokines associated with Plasmodium vivax transmission from acute malaria patients to Anopheles darlingi mosquitoes in the Peruvian Amazon.

Authors:  Shira R Abeles; Raul Chuquiyauri; Carlos Tong; Joseph M Vinetz
Journal:  Am J Trop Med Hyg       Date:  2013-03-11       Impact factor: 2.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.